RealTime SARS-CoV-2 assay
Curbing the COVID-19 outbreak in real-time
Receive your quote directly from the manufacturer.
Fast and precise results.
Detection of anti - N- antibodies IgG against SARS CoV - 2
This test was very useful in my practice during the Covid-19 pandemic to establish available immunity against the SARS-CoV2 virus. Together with the quantitative test for IgG, which is anti-spike IgG in SARS infection, I easily navigated the status of the patient. I had full support from the manufacturer with information about sensitivity, specificity and other characteristics. The test is commercially available.
Review Date: 10 Feb 2023 | Abbott
It's economical
Specialized covid centers
It's economical
Review Date: 15 Jun 2021 | Abbott
Amazing solution!
SARS-CoV-2 Diagnosis
Amazing reliable product and product design! Great work on the product by Abbott in the middle of all the global headwinds due to the pandemic.
Review Date: 6 Jun 2021 | Abbott
Abbott RealTime SARS-CoV-2 assay provides a fully automated solution to help laboratories address the urgent need for automated, high-volume patient testing during the Coronavirus (COVID-19) pandemic.
The assay is engineered with:
- Dual target assay for RdRp and N-genes
- Qualitative detection of nucleic acids from SARS-CoV-2
- maxRatio data analysis removes operator subjectivity
- The Abbott RealTime SARS-CoV-2 assay in combination with the RealTime m2000 system allow scalable, automated process for flexible testing volume (24-96 samples) and up to 470 patient samples in 24 hours.
